quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:17:32·252d
INSIDERFiling
IGM Biosciences Inc. logo

Director Behrens M Kathleen returned 412,535 shares to the company, closing all direct ownership in the company (SEC Form 4)

IGMS· IGM Biosciences Inc.
Health Care
Original source

Companies

  • IGMS
    IGM Biosciences Inc.
    Health Care

Recent analyst ratings

  • Jan 10UpdateBMO Capital Markets$2.00
  • Jan 10UpdateMorgan Stanley$2.00
  • Jan 10UpdateStifel$2.50
  • Jan 10UpdateRBC Capital Mkts$1.50
  • Jan 10UpdateGuggenheim-
  • Dec 6UpdateBMO Capital Markets$21.00

Related

  • SEC241d
    SEC Form 15-12G filed by IGM Biosciences Inc.
  • SEC248d
    Amendment: SEC Form SCHEDULE 13D/A filed by IGM Biosciences Inc.
  • INSIDER248d
    SEC Form 4 filed by Former 10% owner and director Baker Bros. Advisors Lp
  • SEC251d
    Amendment: SEC Form SCHEDULE 13D/A filed by IGM Biosciences Inc.
  • INSIDER251d
    Director Redmile Group, Llc returned 2,964,843 shares to the company (SEC Form 4)
  • SEC252d
    SEC Form EFFECT filed by IGM Biosciences Inc.
  • SEC252d
    SEC Form EFFECT filed by IGM Biosciences Inc.
  • SEC252d
    SEC Form EFFECT filed by IGM Biosciences Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022